Gene: SFR1
Official Full Name: SWI5 dependent homologous recombination repair protein 1provided by HGNC
Gene Summary: Enables nuclear receptor coactivator activity. Involved in cellular response to estrogen stimulus; double-strand break repair via homologous recombination; and positive regulation of DNA-templated transcription. Located in centrosome; nucleolus; and nucleoplasm. Part of Swi5-Sfr1 complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30375 | SFR1 Knockout cell line (HeLa) | Human | SFR1 | 1:3~1:6 | Negative | Online Inquiry |
KO30376 | SFR1 Knockout cell line (HCT 116) | Human | SFR1 | 1:2~1:4 | Negative | Online Inquiry |
KO30377 | SFR1 Knockout cell line (HEK293) | Human | SFR1 | 1:3~1:6 | Negative | Online Inquiry |
SFR1 Gene Knockout Cell Lines are expertly engineered cellular models that have had the SFR1 gene inactivated or deleted, providing researchers with a revolutionary tool for studying gene function and associated biological processes. SFR1, known for its role in regulating cellular responses to stress and its involvement in various physiological functions, is integral to understanding cellular mechanisms related to diseases such as cancer and metabolic disorders.
These cell lines are designed to facilitate detailed functional studies by enabling researchers to observe phenotypic changes that occur due to the absence of SFR1 expression. The knockout mechanism employs CRISPR/Cas9 gene-editing technology, ensuring precise and efficient alterations to the genome. This approach provides researchers with confidence that the observed effects in cellular behavior and biochemical pathways can directly be attributed to the knockout of SFR1, thereby enhancing the quality and reliability of experimental results.
The scientific importance of SFR1 Gene Knockout Cell Lines extends to multiple applications, including drug discovery, gene function studies, and model development for disease mechanisms. In clinical research settings, these cell lines can be utilized to screen for therapeutic compounds, assess drug efficacy, and explore the underlying pathology of diseases linked to SFR1 dysregulation.
What sets our SFR1 Gene Knockout Cell Lines apart from alternative products is the high specificity and uniformity provided through advanced editing techniques, which minimize off-target effects and ensure reproducibility across experiments. Additionally, our cell lines are rigorously validated for consistent performance and biological relevance, making them indispensable tools in molecular biology research.
Researchers and clinicians will find SFR1 Gene Knockout Cell Lines invaluable for their capacity to elucidate complex biological questions, advancing our understanding of gene-environment interactions and disease processes. By incorporating our top-tier biological products into their research or clinical workflows, users can expect to generate high-impact findings that contribute to the evolving landscape of biomedical science.
With a commitment to innovation and quality, our company specializes in producing cutting-edge biological products designed to support the global research community. We pride ourselves on our expertise in genomic technologies and offer an extensive range of cell lines and related products tailored for diverse scientific needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.